Urwashanza/europrocure-10-public-procurement huggingface dataset:
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 29500 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure hydroxychloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Hydroxychloroquine tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply hydroxychloroquine tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the hydroxychloroquine tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of hydroxychloroquine tablets.
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 4 March 2020.


Winner: Sigma Pharmaceuticals
Award value: 29500
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 203870 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure lopinavir/ritonavir tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Lopinavir/ritonavir tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply lopinavir/ritonavir tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the lopinavir/ritonavir tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of lopinavir/ritonavir tablets.
The contracts is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: Accord_UK Ltd
Award value: 203870
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 1020460 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure hydroxychloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the world, in the context of the spread of Covid-19. Hydroxychloroquine tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply hydroxychloroquine tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the hydroxychloroquine tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of hydroxychloroquine tablets.
The contracts is for the benefit of the authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British overseas territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: Blackrock Pharmaceuticals Ltd
Award value: 1020460
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 832200 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure hydroxychloroquine tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the spread of Covid-19. Hydroxychloroquine tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply hydroxychloroquine tablets needed to move quickly to secure this supply. Failure to do this would have resulted in the hydroxychloroquine tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of hydroxychloroquine tablets.
The contracts is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 26 February 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 2 March 2020.


Winner: Zentiva Pharma UK
Award value: 832200
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 3154080 GBP
Award criteria: Lowest price

Technical requirements: A requirement to secure lopinavir/ritonavir tablets for trials for treatments for Covid-19. Urgent delivery required of available stocks.
A situation of extreme urgency exists both in the UK and across the World, in the context of the Covid-19 pandemic. Lopinavir/ritonavir tablets, one of the drugs of choice worldwide for the treatment of Covid-19 is scarce in supply and the contracting authority having identified a supplier that was ready willing and able to supply lopinavir/ritonavir tablets needed to move quickly to secure this supply. Failure to do this would have resulted in lopinavir/ritonavir tablets being sold by the supplier to another country due to the high demand globally. As such and at this time, the timelines for the open procedure, restricted procedure (even where accelerated) and the competitive procedure with negotiation could not be complied with in order for DHSC is to secure this supply of lopinavir/ritonavir tablets.
The contracts is for the benefit of the Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies and the local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health-related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers.
This contract was awarded pursuant to a procurement exercise carried out by the contracting authority to identify suppliers able to urgently supply readily available stocks of antimalarial and anti-retroviral medicinal products for the treatment of Covid-19. This procurement exercise was commenced by the contracting authority on 15 March 2020 and an invitation to negotiate and submit an offer was issued to suppliers in this regard on 18 March 2020.


Winner: HFA Healthcare Products Ltd
Award value: 3154080
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: Offshore Renewable Energy Catapult
Country: UK
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 48321000
Estimated value: 284000 GBP
Award criteria: The most economic tender
EU fund: ERDF

Technical requirements: Provision of engineering simulation and 3D design software, including mechanical CFD and mechanical simulation, modelling and analysis solutions. Maintenance, upgrades and support over 3 years are included.
Whilst it is recognised that other mechanical modelling systems are available. ORE Catapult has invested heavily and standardised on Ansys software over many years, and for compatibility and technical reasons only Ansys software can be used.
The market strategy deployed by Ansys is done in a very deliberate way to allow customers such as Offshore Renewable Energy Catapult to access the required expertise where and when it is needed, either directly or via strategically located channel partners, as in this instance with Wilde Analysis supporting the Blyth site operations. Indeed, Ansys has worked closely with its partner Wilde Analysis to continue their support role to ORE Catapult, as they have an in-depth understanding of the existing technical requirements and work flows being used at the ORE Catapult test and validation site in Blyth. Therefore competition is absent for technical reasons.
Further, ORE Catapult has, over many years, standardised on Ansys software and whilst other mechanical modelling software is available, there would be significant disruption to the business during the implementation of a new system incurring other internal costs e.g. project management, training, in-depth software knowledge accumulation, migration of the existing drawings.


Winner: Ansys
Award value: 284000
Number of bids: 2
Public procurement notice: Modification Of A Contract/Concession During Its Term
Published: 2020-04-29
Buyer: Business Services Organisation, Procurement and Logistics Service on behlaf of the Western Health and Social Care Trust
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 18832000 | 18842000 | 33000000 | 33141700 | 33141740

Technical requirements: Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet
The above contract is due to expire on 31 July 2020. A renewal tender is in process. Given the on-going Covid-19 outbreak it is felt that a change to established supply lines would be inadvisable at this time and it is our intention that the existing contract be extended for a temporary period. This would be in line with Regulation 72(1)(c) of the PCR2015. It is proposed to extend the above contract until 30 April 2021, (prices, terms and conditions remain the same).
Lot 1 Custom Orthoses — this is a shared award with two suppliers (namely Firefly Orthoses Ltd and LBG Medical Ltd). Lot 2 Prefabricated Orthoses — this is a shared award with three suppliers (namely Firefly Orthoses Ltd, MAG Orthotics Ltd and LBG Medical Ltd).


Winner: LBG Medical Ltd
Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2020-04-29
Buyer: NHS Lincolnshire Clinical Commissioning Group
Country: UK
Contract type: Services
CPV classification: 85100000: Health services

Technical requirements: The NHS Lincolnshire Clinical Commissioning Group is undertaking a procurement project (the project) across the county for an NHS111 service. Expressions of interest are invited from suitably qualified and experienced providers capable of delivering an NHS111 service in the county.
As a result of the significant pressure on providers and commissioners in responding to the Covid-19 pandemic this notice is designed to inform the market of the commissioners intention to delay this project for a 12-month period. The delay will allow both the commissioner and the market to focus their resource on responding to the pandemic. Moreover, the delay is designed to encourage greater competition ensuring the market can respond to the invitation to tender when published.
Following the proposed 12-month delay the project will resume. The aim is to commission NHS111 telephony services and/or other services and as specified by the commissioners and directed by national guidance. The procurement will include:
• commission high quality, safe and effective services that meet the urgent care needs of the specified populations across the Lincolnshire health system;
• digitally enabled technologies that support patients in a more convenient and cost effective manner.
This notice is for information only. Please ensure any queries or concerns in relation to this procurement approach are raised prior to the expiry of this notice on 28 May 2020.
Public procurement notice: Contract Notice
Published: 2020-04-29
Buyer: The Royal Borough of Kensington and Chelsea
Country: UK
Contract type: Services
Procedure: Competitive procedure with negotiation
CPV classification: 50870000 | 77310000 | 77313000 | 77314000 | 77320000
Estimated value: 44850000 GBP
Submission deadline: 2020-05-27
Award criteria: The most economic tender

Technical requirements: The parks and landscape maintenance services include 28 parks within the Royal Borough of Kensington and Chelsea, 10 of which have green flag awards. Two cemeteries located out of borough including bereavement services. Playground inspection and maintenance, sports facilities and booking services. The maintenance of 60 street planters, roundabouts and other open spaces across the borough.
This contract includes parks maintenance responsibility for 28 parks, two cemeteries and over 60 additional green spaces, significant to the Council’s green space portfolio; including supply of park keepers and gardeners, waste management, maintenance and improvement of horticultural features, sports facility management (including hire and programmes), conservation and habitat maintenance and creation, cemetery maintenance and bereavement service function. The core aim of the contract is to maintain the Royal Borough’s parks, open spaces, cemeteries, planters and grass verges to a high standard and meet the Council’s long term environmental objectives including delivering its Parks Strategy (2016-2025) and becoming carbon neutral by 2030.
The candidates will be short listed to a minimum of three at the ISIT and negotiation stage, as detailed in the procurement documents.


Award value: 44850000
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: Business Services Organisation
Country: UK
Contract type: Services
Procedure: Negotiated without a prior call for competition
CPV classification: 72000000
Estimated value: 617577 GBP
Award criteria: Lowest price

Technical requirements: Υπηρεσίες τεχνολογίας των πληροφοριών: παροχή συμβουλών, ανάπτυξη λογισμικού, Διαδίκτυο και υποστήριξη
Varian are the single supplier of the Aria MO and they provide support of the main system and their bespoke interface engine. The system is a highly specialised system which is used to support cancer services in all five health trusts in the HSCNI. The interface engine allows inbound and outbound messages which provide essential clinical information to those treating cancer patients.
Varian are the only company that possess the expertise to maintain the system ensuring continued service delivery. New extension of this contract would be from April 2020 until March 2023 with the option to extend for a further period of 2 x 1 year extensions — (April 2023-March 2024; April 2024-March 2025). The encompass programme will replace many of HSC's aging and obsolete technology. as well as, add functionality which is currently not available in HSCNI. The encompass team have confirmed that RISOH is out of scope and that Epic does have an oncology module (Beacon) which is part of the enterprise licence but there is no implementation of it included at this stage. Whilst RISOH is not currently within scope, this may be reviewed during its programme lifecycle. Therefore the contract term will enable these reviews to take place and action accordingly.
To continue to support the Varian ARIA MO system which is in clinical use region wide by cancer services — currently RISOH has in excess of:
Therefore it is better value for money to remain with the current system and supplier. It would be a risk to trusts as this is a highly specialised system and any change would require minimum retraining of all staff.
Varian are the single supplier of the Aria MO and they provide support of the main system and their bespoke interface engine. The system is a highly specialised system which is used to support cancer services in all five trusts in the HSCNI.


Winner: Varian Medical Systems
Award value: 617577
Number of bids: 1
Public procurement notice: Contract Award Notice
Published: 2020-04-29
Buyer: CPD — Construction Division
Country: UK
Contract type: Services
Procedure: Restricted procedure
CPV classification: 71000000 | 71220000 | 71540000: Construction management services
Estimated value: 375670 GBP
Award criteria: The most economic tender

Technical requirements: DE 2264563 Appointment of an Integrated Consultant Team for St Kevin's College, Lisnaskea — School Enhancement Programme - SEP2-48
The objective of this procurement is the provision of construction related professional services by a team of consultants and their supply chain, collectively referred to as the Integrated Consultant Team (ICT). The ICT will actively develop the employer's requirements, prepare the concept and developed design for new teaching accommodation building(s) and associated site works and shall provide professional services applicable to all RIBA Plan of Work 2013 Stage 1-7. The contract will be awarded to the ICT which has submitted the most economically advantageous tender (MEAT) based on the narrow average price scoring mechanism. For full description refer to invitation to tender, document 3 of 4 — Scope of services.
The objective of this procurement is the provision of construction related professional services by a team of consultants and their supply chain, collectively referred to as the Integrated Consultant Team (ICT). The ICT will actively develop the employer's requirements, prepare the concept and developed design for new teaching accommodation building(s) and associated site works and shall provide professional services applicable to all RIBA Plan of Work 2013 Stage 1-7. The contract will be awarded to the ICT which has submitted the most economically advantageous tender (MEAT) based on the narrow average price scoring mechanism. For full description refer to invitation to tender, Document 3 of 4 — Scope of services.


Winner: Samuel Stevenson Sons Ltd
Award value: 375670
Number of bids: 16